Thermo Fisher Scientific Inc (TMO) 156.00 $TMO Zacks.com

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Thermo Fisher Scientific Inc (TMO) 156.00 $TMO

Zacks.com featured highlights: CBS, Alliance Data Systems, Heartland Financial, Aetna and Thermo Fisher Scientific
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 8:30AM CDT
Zacks.com featured highlights: CBS, Alliance Data Systems, Heartland Financial, Aetna and Thermo Fisher Scientific
TMO: 156.00 (-0.44), HTLF: 36.37 (+0.36), AET: 116.86 (+1.15), ADS: 222.32 (-0.27), CBS: 52.09 (+0.18)

Thermo Fisher Scientific Falls 1.87% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Aug 02, 2:21PM CDT
Thermo Fisher Scientific (NYSE:TMO) traded in a range yesterday that spanned from a low of $156.12 to a high of $159.79. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $156.56 on volume of 802,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TMO: 156.00 (-0.44)

Thermo Fisher Scientific Set to Possibly Rebound After Yesterday's Selloff of 1.87%
Comtex SmarTrend(R) - Tue Aug 02, 2:20PM CDT
Thermo Fisher Scientific (NYSE:TMO) traded in a range yesterday that spanned from a low of $156.12 to a high of $159.79. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $156.56 on volume of 802,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TMO: 156.00 (-0.44)

5 GARP Stocks for Alluring Returns
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 7:19AM CDT
Investors seeking stocks that have the potential to offer the best of growth as well as value investing may consider the investing strategy known as growth at a reasonable price or GARP
TMO: 156.00 (-0.44), HTLF: 36.37 (+0.36), AET: 116.86 (+1.15), ADS: 222.32 (-0.27), CBS: 52.09 (+0.18)

Thermo Fisher Scientific Expands Offering for Clinical Applications at AACC 2016
BusinessWire - Mon Aug 01, 7:00AM CDT
AACC 2016 - Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, will exhibit its expanded offering of new assays, instruments and software at the 2016 American Association of Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo being held July 31 - August 4 at the Pennsylvania Convention Center. Designed specifically for customers working in research and clinical settings, these innovative new products will be on display in booths #2334 and #2145.
TMO: 156.00 (-0.44)

Top 7 Research Reports for July 29, 2016
Sheraz Mian - Zacks Investment Research - Fri Jul 29, 12:44PM CDT
Top 7 Research Reports for July 29, 2016
MDLZ: 43.10 (+0.07), JPM: 64.66 (+1.01), TMO: 156.00 (-0.44), AMGN: 173.43 (-0.72), LLY: 82.72 (-0.60), TM: 110.07 (+0.10), ORCL: 40.71 (unch)

Thermo Fisher (TMO) Tops Q2 Earnings, Sales; Updates View
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 2:31PM CDT
Thermo Fisher's (TMO) financial numbers squarely beat the Zacks Consensus Estimate in the second quarter
BABY: 38.40 (-0.05), ABMD: 118.58 (-0.33), MASI: 53.18 (+0.64), TMO: 156.00 (-0.44)

Thermo Fisher Scientific (TMO) Breaks Through Support at $157.75
Comtex SmarTrend(R) - Thu Jul 28, 8:45AM CDT
Shares of Thermo Fisher Scientific (NYSE:TMO) have bearishly opened below the pivot of $158.62 today and have reached the first support level of $157.75. Investors may be interested in a cross of the next downside pivot targets of $156.60 and $154.58.
TMO: 156.00 (-0.44)

Thermo Fisher (TMO) Tops Q1 Earnings, Lowers '16 Sales View
Aparajita Dutta - Zacks Investment Research - Thu Jul 28, 6:59AM CDT
Thermo Fisher's (TMO) adjusted earnings per share of $2.03 beat the Zacks Consensus estimate by 1.5%.
TMO: 156.00 (-0.44)

Thermo Fisher Scientific Reports Second Quarter 2016 Results
BusinessWire - Thu Jul 28, 5:00AM CDT
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter of 2016, ended July 2, 2016.
TMO: 156.00 (-0.44)

Thermo Fisher Scientific Rises 1.78% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Jul 14, 12:28PM CDT
Thermo Fisher Scientific (NYSE:TMO) traded in a range yesterday that spanned from a low of $155.70 to a high of $157.73. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $155.17 on volume of 794,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TMO: 156.00 (-0.44)

MedTech Tailwinds at a Glance: Which Stocks to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 5:02PM CDT
MedTech Tailwinds at a Glance: Which Stocks to Buy?
ABMD: 118.58 (-0.33), LDRH: 36.98 (-0.02), MDT: 86.67 (-0.97), PAHC: 21.02 (+0.05), MLAB: 105.13 (-3.14), NUVA: 62.76 (+0.13), BSX: 23.84 (-0.33), BABY: 38.40 (-0.05), SNN: 33.20 (-0.28), JNJ: 123.90 (-0.95), DXCM: 90.87 (-1.91), GWPH: 95.02 (+0.95), RMD: 68.80 (-0.58), WOOF: 70.57 (+0.87), ABT: 44.95 (-0.12), VIVO: 19.42 (+0.13), MASI: 53.18 (+0.64), TMO: 156.00 (-0.44), CYH: 12.39 (+0.19), HTWR: 57.94 (+0.05), FEIC: 106.60 (-0.05), ISRG: 687.73 (-2.76), CFMS: 6.95 (+0.12), STE: 70.64 (-0.12), STJ: 83.53 (+0.01), XRAY: 65.14 (+0.51), HOLX: 39.00 (-0.03)

Thermo Fisher Scientific Declares Quarterly Dividend and Authorizes $1.5 Billion of Share Repurchases
BusinessWire - Thu Jul 07, 3:30PM CDT
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors declared a quarterly cash dividend of $0.15 per share. The dividend will be paid on October 17, 2016, to shareholders of record as of September 15, 2016.
TMO: 156.00 (-0.44)

Medical Device Consolidation Frenzy: Here's How to Play it
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:00AM CDT
The medical device majors struggling with their core businesses are often on the lookout for emerging therapies through acquisitions and alliances.
ABT: 44.95 (-0.12), JNJ: 123.90 (-0.95), ZBH: 130.43 (-0.16), LDRH: 36.98 (-0.02), MDT: 86.67 (-0.97), TMO: 156.00 (-0.44), STJ: 83.53 (+0.01), HTWR: 57.94 (+0.05), XRAY: 65.14 (+0.51), NUVA: 62.76 (+0.13), FEIC: 106.60 (-0.05)

Thermo Fisher Grows Globally; Affimetrix Synergy on Track
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 7:17AM CDT
On Jun 20, 2016, we issued an updated research report on Thermo Fisher Scientific Inc. (TMO).
MASI: 53.18 (+0.64), TMO: 156.00 (-0.44), CRY: 14.00 (-0.25), MLAB: 105.13 (-3.14)

SmarTrend Watching for Potential Rebound in Shares of Thermo Fisher Scientific After 1.74% Loss
Comtex SmarTrend(R) - Tue Jun 14, 1:15PM CDT
Thermo Fisher Scientific (NYSE:TMO) traded in a range yesterday that spanned from a low of $147.13 to a high of $149.82. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $150.44 on volume of 818,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
TMO: 156.00 (-0.44)

Premarket Research Report Covering the Medical Laboratories & Research Industry
ACCESSWIRE - Thu Jun 09, 8:17AM CDT
LONDON, UK / ACCESSWIRE / June 9, 2016 / ActiveWallSt.com announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Medical Laboratories & Research industry. Companies recently under review include Thermo Fisher Scientific, Great Basin Scientific, PerkinElmer, and Organovo. Register with us now for your free membership and see our complete reports on these equities at:
GBSN: 0.29 (-0.05), TMO: 156.00 (-0.44), ONVO: 4.40 (+0.15), PKI: 55.75 (-0.16)

Thermo Fisher Scientific Strengthens Life Sciences Leadership with New Instruments Launched at ASMS 2016
BusinessWire - Mon Jun 06, 7:00AM CDT
Thermo Fisher Scientific Inc., (NYSE: TMO), the world leader in serving science, strengthened its industry-leading analytical instruments platform with innovative systems designed to help pharmaceutical and biologics producers more efficiently discover and develop candidate drugs. These new products will be on display at the 64th Annual American Society for Mass Spectrometry (ASMS) Conference, June 5-9 in Texas Ballroom D at the Grand Hyatt Hotel.
TMO: 156.00 (-0.44)

FEI COMPANY SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
BusinessWire - Wed Jun 01, 12:21PM CDT
Rigrodsky & Long, P.A.:
TMO: 156.00 (-0.44), FEIC: 106.60 (-0.05)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 371

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 375

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 312

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 386

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 389

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 122

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 299

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 488

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading

Top 5 Most Recently Viewed Articles

GreenPower Motor Company Aims for Enhanced Growth by Delisting

Updated Category News Views 218

GreenPower Motor Company Announces Delisting Decision GreenPower Motor Company Inc. (NASDAQ: GP) is making a significant move in its growth strategy. The company, which is renowned for manufacturing and distributing all-electric vehicles tailored for medium and heavy-duty applications, has decided to voluntarily delist its shares from the TSX Venture Exchange (the...

Continue Reading
VEON Announces Q4 2024 Trading Update Conference Details

Updated Category News Views 264

VEON Announces Q4 2024 Trading Update Conference Details Dubai – VEON Ltd. (NASDAQ: VEON), a prominent digital operator, has confirmed the upcoming release of significant financial information regarding its fourth quarter and full year ending December 31, 2024. This update will occur around 10:00 GST (2:00 EST) on March 20, 2025. In addition to the financial update,...

Continue Reading
Netcapital's Revenue Fraud Scandal Hits Investor Confidence

Updated Category News Views 206

The Rise and Fall of Netcapital: A Troubling Drop Netcapital Inc. (NASDAQ: NCPL) has found itself in hot water with investors after revelations of a wild scheme to fluff up its revenue figures. It’s like watching a house of cards crumble — and investors are left holding the bag. From December 15, 2021, through September 3, 2026, a slew of misinformation allegedly...

Continue Reading
Honoring Lt. Thomas V. Kelly Jr.: A Hero's Long-Awaited Return

Updated Category News Views 394

Honoring Lt. Thomas V. Kelly Jr.: A Hero's Long-Awaited Return This Memorial Day weekend marks a significant moment in history as the San Francisco East Bay welcomes back a hero after eight decades. The community prepares for a heartfelt homecoming for 2nd Lt. Thomas V. Kelly Jr., who served valiantly as a bombardier during World War II. A Journey Through History Born in...

Continue Reading
TOMY's Zoids Ultrasaurus: Gun for Nostalgia and Growth

Updated Category News Views 28

Unlocking the Power of Nostalgia with TOMY's Ultrasaurus Nostalgia isn't just an emotion; it's a powerful force that can drive sales like nobody's business, and TOMY Company knows this well. They're rolling out the big guns—literally—by adding the animated series' beloved Gravity Cannon to their new AZ-17DX Ultrasaurus model. How's that for a hook? The Gravity Cannon...

Continue Reading